 Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26
Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26 Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore
Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore
National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore NOCIL Ltd Q2 FY2025-26 consolidated profit declines to Rs. 12.12 crores
NOCIL Ltd Q2 FY2025-26 consolidated profit declines to Rs. 12.12 crores IFB Agro Industries Ltd consolidated Q2FY26 net profit surges to Rs. 22.70 crores
IFB Agro Industries Ltd consolidated Q2FY26 net profit surges to Rs. 22.70 crores 
              HUL posted strong set of results with 34.6% revenue growth led by 16% volume growth. Though the growth was aided by the low base quarter & consolidation of foods business, discretionary categories also saw a sharp recovery in Q4FY21. Home care and beauty & personal care (BPC) segments witnessed growth of 14.6% & 19.7%, respectively. Detergent category, which was adversely impacted in 9MFY21 saw strong recovery in Q4 due to increase in out of home activity. The growth in BPC category was also driven by volume as well as calibrated price hikes in the soaps category. Foods business grew 96% due to consolidation of nutrition business but on a like-to-like basis, the segment growth was 36%. Gross margins contracted 117 bps mainly on account of a sharp increase in palm oil, tea & crude based raw material prices. However, the company was able to pass on the increase in raw material cost partially in the last six months. Marketing spends & other overhead spends were down 127 bps & 172 bps, respectively. This helped the company grow its operating profit by 43.2% to Rs. 2957 crore. Operating margins improved 146 bps to 24.4%. Led by strong operating profit growth, PAT witnessed growth of 41.1% to Rs. 2143 crore. The company declared a final dividend of Rs. 17/share.
Valuation & Outlook
Given strong growth in nutrition business, judicious price hikes and continued strong growth in hygiene & foods business, we estimate 11.8% revenue growth in FY21-23E. We believe synergetic benefits of acquired nutrition brands would reflect in margin expansion, going forward, and expect earnings CAGR of 15.3% in FY21-23E. We change our rating from HOLD to BUY with a revised TP of Rs. 2715/share (earlier Rs. 2600).
For details, click on the link below: https://www.icicidirect.com/mailimages/IDirect_HUL_Q4FY21.pdf
Shares of HINDUSTAN UNILEVER LTD. was last trading in BSE at Rs.2353.85 as compared to the previous close of Rs. 2409.05. The total number of shares traded during the day was 178827 in over 16485 trades.
The stock hit an intraday high of Rs. 2444.45 and intraday low of 2331. The net turnover during the day was Rs. 422662868.